We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Ashvattha Therapeutics Stock

Invest in or calculate the value of your shares in Ashvattha Therapeutics or other pre-IPO companies through EquityZen's platform.

Get Started

Ashvattha Therapeutics Stock (ASHT)

Ashvattha Therapeutics is a biotechnology company that creates products that selectively target and treat human diseases.

About Ashvattha Therapeutics Stock

Founded

2015

Headquarters

Redwood City, CA, US

Industries

Software, Artificial Intelligence, Data and Analytics

Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.

Ashvattha Therapeutics Management

Leadership team at Ashvattha Therapeutics

Board Director

Jay Zaveri

CBO

Matt Brewer

Locked Features

Join now and verify your accreditation status to gain access to:

  • Ashvattha Therapeutics current valuation
  • Ashvattha Therapeutics stock price
  • Available deals in Ashvattha Therapeutics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Ashvattha Therapeutics stock?

Accredited investors can buy pre-IPO stock in companies like Ashvattha Therapeutics through EquityZen funds. These investments are made available by existing Ashvattha Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Ashvattha Therapeutics stock?

Shareholders can sell their Ashvattha Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."